13th edition

Format
HYBRID

December 3rd & 4th, 2024

IN-PERSON | LILLE, FR

December 11th& 12th 2024

ONLINE MEETINGS

Stand G9

2022 Edition

Ciloa SAS

fr

Bio-engineered Exosomes to tackle diabetes, inflammation, infectious diseases and more.
Ciloa is the most experienced exosome-based R&D power house dedicated to the development of preventive and therapeutic innovative solutions using a patented technology to bio-engineer exosomes. Its technology provides solutions to the major challenges in the development of exosome-based bio-therapeutics which are: targeting specificity, cargo loading, stability, and production of large amounts of pure exosome.

Scroll to Top
  • No products in the cart.